EUVIMEDEUVIMED entdecken
Open Access

Exploring the Impact of the Multimodal CAPABLE eHealth Intervention on Health-Related Quality of Life in Patients With Melanoma Undergoing Immune-Checkpoint Inhibition: Prospective Pilot Study

Itske Fraterman iD, Lucia Sacchi iD, Henk Mallo iD, Valentina Tibollo iD, Savannah Lucia Catherina Glaser iD, Stephanie Medlock iD, Ronald Cornet iD, Matteo Gabetta iD, Vitali Hisko iD, Vadzim Khadakou iD, Ella Barkan iD, Laura Del Campo iD und 16 weitere

JMIR Cancer · 2025

DOI: 10.2196/58938 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JMIR Cancer, 2025. Verfasst von Itske Fraterman und 27 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066CX, Netherlands, 31 062188591…. Hauptthemen laut MEDLINE: Quality of Life, Melanoma, Immune Checkpoint Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients with melanoma receiving immunotherapy with immune-checkpoint inhibitors often experience immune-related adverse events, cancer-related fatigue, and emotional distress, affecting health-related quality of life () and clinical outcome to immunotherapy. eHealth tools can aid patients with cancer in addressing issues, such as adverse events and psychosocial well-being, from various perspectives.

Objective

This study aimed to explore the effect of the Cancer Patients Better Life Experience (CAPABLE) system, accessed through a mobile app, on HRQoL compared with a matched historical control group receiving standard care. CAPABLE is an extensively tested eHealth app, including educational material, remote symptom monitoring, and well-being interventions.

Methods

This prospective pilot study compared an exploratory cohort that received the CAPABLE smartphone app and a multisensory smartwatch for 6 months (intervention) to a 2:1 individually matched historical prospective control group. HRQoL data were measured with the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 at baseline (T0), 3 months (T1), and 6 months (T2) after start of treatment. Mixed effects linear regression models were used to compare HRQoL between the 2 groups over time.

Results

From the 59 eligible patients for the CAPABLE intervention, 31 (53%) signed informed consent to participate. Baseline HRQoL was on average 10 points higher in the intervention group compared with controls, although equally matched on baseline and clinical characteristics. When correcting for sex, age, disease stage, and baseline scores, an adjusted difference in fatigue of −5.09 (95% CI −15.20 to 5.02, P= .32) at month 3 was found. No significant nor clinically relevant adjusted differences on other HRQoL domains over time were found. However, information satisfaction was significantly higher in the CAPABLE group (β=8.71, 95% CI 1.54‐15.88, P =.02).

Conclusions

The intervention showed a limited effect on HRQoL, although there was a small improvement in fatigue at 3 months, as well as information satisfaction. When aiming at personalized patient and survivorship care, further optimization and prospective investigation of eHealth tools is warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality of LifeMelanomaImmune Checkpoint InhibitorsHumansPilot ProjectsMaleFemaleProspective StudiesMiddle AgedTelemedicineAgedMobile ApplicationsAdultSurveys and Questionnaires

Stichwörter der Autor:innen

patientappcancereHealthexploratoryfatiguefeasibilityhealth-relatedimmune-checkpoint inhibitorimmune-relatedimmunotherapyinterventioninterventionslinear regression modelmelanoma

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066CX, Netherlands, 31 0621885919.
  • Department of Electric, Computer and Biomedical Engineering, University of Pavia, Pavia, Italy.
  • Department of Medical Oncology, Antoni van Leeuwenhoek, Amsterdam, Netherlands.
  • Laboratory of Informatics and Systems Engineering for Clinical Research, Istituti Clinici Scientifici Maugeri SpA SB IRCCS, Pavia, Italy.
  • Medical Informatics, Amsterdam UMC - University of Amsterdam, Amsterdam, Netherlands.
  • Methodology and Digital Health, Amsterdam Public Health, Amsterdam, Netherlands.

ORCID-Profile: Itske Fraterman, Lucia Sacchi, Henk Mallo, Valentina Tibollo, Savannah Lucia Catherina Glaser, Stephanie Medlock, Ronald Cornet, Matteo Gabetta, Vitali Hisko, Vadzim Khadakou, Ella Barkan, Laura Del Campo, David Glasspool, Alexandra Kogan, Giordano Lanzola, Roy Leizer, Manuel Ottaviano, Mor Peleg, Konrad Śniatała, Aneta Lisowska, Szymon Wilk, Enea Parimbelli, Silvana Quaglini, Mimma Rizzo, Laura Deborah Locati, Annelies Boekhout, Lonneke V van de Poll-Franse, Sofie Wilgenhof

Zitieren

APA

Fraterman, I., Sacchi, L., Mallo, H., Tibollo, V., Glaser, S. L. C., Medlock, S., Cornet, R., Gabetta, M., Hisko, V., Khadakou, V., Barkan, E., Del Campo, L., Glasspool, D., Kogan, A., Lanzola, G., Leizer, R., Ottaviano, M., Peleg, M., Śniatała, K., …, & Wilgenhof, S. (2025). Exploring the Impact of the Multimodal CAPABLE eHealth Intervention on Health-Related Quality of Life in Patients With Melanoma Undergoing Immune-Checkpoint Inhibition: Prospective Pilot Study. JMIR Cancer. https://doi.org/10.2196/58938

Vancouver

Fraterman I, Sacchi L, Mallo H, Tibollo V, Glaser SLC, Medlock S, et al. Exploring the Impact of the Multimodal CAPABLE eHealth Intervention on Health-Related Quality of Life in Patients With Melanoma Undergoing Immune-Checkpoint Inhibition: Prospective Pilot Study. JMIR Cancer. 2025. doi:10.2196/58938

BibTeX
@article{Fraterman2025,
  author = {Fraterman, Itske and Sacchi, Lucia and Mallo, Henk and Tibollo, Valentina and Glaser, Savannah Lucia Catherina and Medlock, Stephanie and Cornet, Ronald and Gabetta, Matteo and Hisko, Vitali and Khadakou, Vadzim and Barkan, Ella and Del Campo, Laura and Glasspool, David and Kogan, Alexandra and Lanzola, Giordano and Leizer, Roy and Ottaviano, Manuel and Peleg, Mor and Śniatała, Konrad and Lisowska, Aneta and Wilk, Szymon and Parimbelli, Enea and Quaglini, Silvana and Rizzo, Mimma and Locati, Laura Deborah and Boekhout, Annelies and van de Poll-Franse, Lonneke V and Wilgenhof, Sofie},
  title = {Exploring the Impact of the Multimodal CAPABLE eHealth Intervention on Health-Related Quality of Life in Patients With Melanoma Undergoing Immune-Checkpoint Inhibition: Prospective Pilot Study},
  journal = {JMIR Cancer},
  year = {2025},
  doi = {10.2196/58938}
}
Kostenlos starten →